Legal Opinion
In Re Baycol Products Litigation
District Court, D. Minnesota
Decided July 16, 2007No. MDL 1431PublishedCited by 36 opinions
1Opinion of the Court
AMENDED MEMORANDUM OPINION AND ORDER
MICHAEL J. DAVIS, District Judge.
This matter is before the Court on the parties’ motions to exclude certain expert testimony.
BACKGROUND
This action involves the prescription drug, Cerivastatin, which was marketed in the United States under the brand name Baycol. Cerivastatin is a member of a class of drug known as statins that have been routinely prescribed to lower the lipid levels of individuals with high cholesterol, with the goal of decreasing the risk of cardiac diseases. Statins have been available since the late 1980’s and have been widely prescribed.
B…
2Cases cited26 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- Ruiz-Troche v. Pepsi Cola of Puerto Rico Bottling Co.Court of Appeals for the First Circuit · 1998
21 more not listed; retrieve them via the Exa API.
3Cited by36 opinions
- In Re Fosamax Products Liability LitigationDistrict Court, S.D. New York · 2009
- In re Mirena IUD Products Liability LitigationDistrict Court, S.D. New York · 2016
- In re E.I. Du Pont De Nemours & Co. C-8 Personal Injury Litig.District Court, S.D. Ohio · 2016
- Deutsch Ex Rel. Estate of Deutsch v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2011
- Tillman v. C.R. Bard, Inc.District Court, M.D. Florida · 2015
31 more not listed; retrieve them via the Exa API.